SHL Telemedicine (SHMLF) director reports direct and indirect stakes

Rhea-AI Filing Summary

SHL Telemedicine Ltd director Ido Nouberger filed a Form 3 reporting his ownership of the company’s ordinary shares. The filing shows he holds 1,504,224 ordinary shares directly. It also reports 3,832,720 ordinary shares owned indirectly through Value Base Ltd. and certain affiliates.

The footnote explains that Mr. Nouberger, together with Victor Shamrich, controls Value Base Ltd. and that he disclaims beneficial ownership of the indirectly held shares except to the extent of his pecuniary interest. The entries are reported as holdings rather than new buy or sell transactions.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Nouberger Ido

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 1,504,224 shares (Direct); Ordinary Shares — 3,832,720 shares (Indirect, See Footnote)

Footnotes (1)

1. [object Object]

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nouberger Ido

(Last) (First) (Middle)

C/O SHL TELEMEDICINE LTD.

90 YIGAL ALON STREET

(Street)

TEL AVIV 67891

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SHL TELEMEDICINE LTD [ SHLT ]

3a. Foreign Trading Symbol
[SHLTN]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	1,504,224	D
Ordinary Shares	3,832,720	I	See Footnote(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents ordinary shares beneficially owned by Value Base Ltd. and certain affiliates. Mr. Nouberger, together with Mr. Victor Shamrich, controls Value Base Ltd. Mr. Nouberger disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Remarks:

This Form 3 is filed pursuant to the Holding Foreign Insiders Accountable Act (HFIAA), which extends Section 16(a) reporting obligations to directors and officers of Foreign Private Issuers effective March 18, 2026.

	/s/ Noubergar Ido	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the SHL Telemedicine (SHMLF) Form 3 for Ido Nouberger show?

The Form 3 reports director Ido Nouberger’s existing ownership in SHL Telemedicine. It lists 1,504,224 ordinary shares held directly and 3,832,720 shares held indirectly through Value Base Ltd. and affiliates, establishing his baseline stake as an insider.

How many SHL Telemedicine ordinary shares does Ido Nouberger hold directly?

The filing shows Nouberger directly holds 1,504,224 ordinary shares of SHL Telemedicine. This direct position reflects shares registered in his own name, separate from additional stakes reported as indirectly owned through related entities.

What indirect SHL Telemedicine holdings are attributed to Value Base Ltd.?

The Form 3 reports 3,832,720 SHL Telemedicine ordinary shares as beneficially owned by Value Base Ltd. and certain affiliates. Nouberger and Victor Shamrich control Value Base Ltd., linking these indirect holdings to entities they manage rather than to Nouberger personally.

How does Ido Nouberger treat beneficial ownership of indirect SHL Telemedicine shares?

Nouberger disclaims beneficial ownership of the indirect shares except for his pecuniary interest. This means he acknowledges only the economic portion that benefits him, even though the shares are reported as beneficially owned by Value Base Ltd. and its affiliates.

Does this SHL Telemedicine Form 3 disclose insider buying or selling activity?

The entries are classified as holdings with unknown transaction codes and zero buy or sell counts in the summary. This indicates the Form 3 establishes Nouberger’s existing ownership positions rather than reporting new purchase or sale transactions.